Cardinal Health has agreed to contribute its Outcomes business to Transaction Data Systems (TDS) in exchange for a minority stake in the combined entity. TDS, based in Orlando, already offers clinical pharmacy solutions. The merger will provide more opportunities for pharmacists to participate in clinical interventions and improve access to care and outcomes for patients.
What You Should Know:
- Cardinal Health today announced it has signed a definitive agreement to contribute its Outcomes™ business to Orlando-based Transaction Data Systems (TDS) in exchange for a minority stake in the combined entity.
- Under the terms of the merger agreement, Cardinal Health’s pharmaceutical segment CEO, Debbie Weitzman, will be appointed to theTDS board of directors.
- TDS’s existing portfolio of clinical pharmacy solutions includes the Rx30 and Computer-Rx pharmacy management systems and PrescribeWellness.
- Together, TDS and Outcomes will create additional opportunities for pharmacists to participate in sponsored clinical interventions and better access for payors and pharmaceutical companies to drive better care and outcomes for patients.
Source: HitConsultant
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
